MDT - Medtronic plc

NYSE - NYSE Delayed Price. Currency in USD
93.72
-1.78 (-1.86%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close95.50
Open94.40
Bid91.51 x 800
Ask99.78 x 2200
Day's Range93.11 - 94.76
52 Week Range76.41 - 100.15
Volume6,337,838
Avg. Volume5,289,620
Market Cap125.871B
Beta (3Y Monthly)0.66
PE Ratio (TTM)58.80
EPS (TTM)1.59
Earnings DateFeb 19, 2019
Forward Dividend & Yield2.00 (2.12%)
Ex-Dividend Date2018-09-27
1y Target Est104.32
Trade prices are not sourced from all markets
  • Undervalued Medtronic Looks Like a Healthy Buy
    Morningstar8 days ago

    Undervalued Medtronic Looks Like a Healthy Buy

    The wide-moat medical device firm is well-positioned to leverage value-based reimbursement and risk-based contracts.

  • How Did Medtronic’s Restorative Therapies Group Perform?
    Market Realist21 hours ago

    How Did Medtronic’s Restorative Therapies Group Perform?

    Who Is Eyeing Medtronic Now? Medtronic’s (MDT) Spine Therapies generated revenues of $1.3 billion in the first half of fiscal 2019. Medtronic’s (MDT) Brain Therapies generated revenues of $1.2 billion in the first half of fiscal 2019, reflecting ~11% YoY growth.

  • How Medtronic’s Minimally Invasive Therapies Group Has Performed
    Market Realist2 days ago

    How Medtronic’s Minimally Invasive Therapies Group Has Performed

    Medtronic’s (MDT) Minimally Invasive Therapies Group (or MITG) consists of the Surgical Innovations (or SI), and Respiratory, Gastrointestinal & Renal (or RGR) segments.

  • A Look at Medtronic’s Cardiac & Vascular Group’s Revenue Streams
    Market Realist2 days ago

    A Look at Medtronic’s Cardiac & Vascular Group’s Revenue Streams

    Medtronic’s Cardiac & Vascular Group consists of the Cardiac Rhythm & Heart Failure (or CRHF), the Coronary & Structural Heart (or CSH), and Aortic, Peripheral & Venous (or APV) segments.

  • How Medtronic’s Cardiac and Vascular Group Performed
    Market Realist2 days ago

    How Medtronic’s Cardiac and Vascular Group Performed

    Medtronic’s (MDT) Cardiac & Vascular Group generated revenues of $2.9 billion in the second quarter of fiscal 2019 compared to $2.8 billion in the second quarter of fiscal 2018, reflecting ~3% YoY growth.

  • A Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019
    Market Realist3 days ago

    A Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019

    Medtronic (MDT) reported net income of $1.1 billion in the second quarter of fiscal 2019 compared to $2.0 billion in the second quarter of fiscal 2018. Medtronic’s net income in the first half of fiscal 2019 totaled $2.2 billion compared to $3.0 billion in the same period the prior year. Wall Street analysts anticipate that Medtronic is expected to report net income of $1.25 billion in the third quarter of fiscal 2019.

  • How Medtronic’s Revenues and Expenses Are Trending
    Market Realist3 days ago

    How Medtronic’s Revenues and Expenses Are Trending

    Medtronic (MDT) reported net revenues of $7.5 billion in the second quarter of fiscal 2019 compared to $7.1 billion in the second quarter of fiscal 2018, reflecting 6% YoY growth.

  • How Wall Street Analysts View Medtronic in December
    Market Realist3 days ago

    How Wall Street Analysts View Medtronic in December

    In November, Medtronic announced that the company would acquire Nutrino Health, a company that specializes in nutrition associated data services, analytics, and technologies. Medtronic’s diabetes segment is expected to improve significantly with the acquisition of Nutrino Health. The acquisition of Nutrino Health will bring together Nutrino Health’s robust food database, expertise in nutrition science and food analysis systems, and Medtronic’s innovative diabetes management resources.

  • Medtronic (MDT) Stock Moves -0.01%: What You Should Know
    Zacks3 days ago

    Medtronic (MDT) Stock Moves -0.01%: What You Should Know

    Medtronic (MDT) closed at $95.47 in the latest trading session, marking a -0.01% move from the prior day.

  • Medtronic Named One of America's Best Corporate Citizens in 2018 by Forbes Magazine
    GlobeNewswire5 days ago

    Medtronic Named One of America's Best Corporate Citizens in 2018 by Forbes Magazine

    December 10, 2018 - Medtronic plc (MDT), the global leader in medical technology, today announced it has been named one of America`s Most JUST Companies in 2018, according to Forbes magazine and JUST Capital, a nonprofit that ranks publicly-traded corporations on the issues Americans care about most. Medtronic was ranked 61st on this year`s JUST 100: America`s Best Corporate Citizens list for outperforming its peers in areas such as fair treatment of employees, job creation, customer treatment, and product quality. To determine the ranking, Forbes and JUST Capital surveyed more than 81,000 Americans over four years and asked what people prioritize most regarding corporate behavior today.

  • Zacks5 days ago

    Insulet Gains on Omnipod Reimbursement Update, Rivalry Stiff

    Insulet Corporation (PODD) continues to expand Omnipod's market access on growing reimbursements. The company operates in a highly competitive environment.

  • Hedge Funds Are Betting On Medtronic, Inc. (MDT)
    Insider Monkey7 days ago

    Hedge Funds Are Betting On Medtronic, Inc. (MDT)

    A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]

  • CNW Group8 days ago

    Medtronic Canada Recognized as One of Greater Toronto's Top Employers for 2019

    BRAMPTON, ON , Dec. 7, 2018 /CNW/ - Medtronic of Canada Ltd., an indirect subsidiary of Medtronic plc (MDT) announced today that it has been recognized as one of the Greater Toronto's Top Employers for 2019. Medtronic's philanthropic and employee-led activities, along with a top tier benefits package, are among some of the many reasons Medtronic is considered a top employer. The Medtronic Mission is another reason why people join and stay at Medtronic.

  • GlobeNewswire8 days ago

    Detailed Research: Economic Perspectives on ResMed, Proofpoint, Southwestern Energy, Knowles, Chipotle Mexican Grill, and Medtronic — What Drives Growth in Today's Competitive Landscape

    NEW YORK, Dec. 07, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2019
    GlobeNewswire8 days ago

    Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2019

    December 7, 2018 - The board of directors of Medtronic plc (MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2018. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 41 consecutive years.

  • Motley Fool9 days ago

    What Happens to My Stock When a Company in My Portfolio Is Acquired?

    Do shareholders automatically get shares in the new company? Or cash? Or does one need to actively do something to make it all happen?

  • Jeffrey Talpins’ Top Stock Picks
    Insider Monkey10 days ago

    Jeffrey Talpins’ Top Stock Picks

    If you are looking for the best ideas for your portfolio you may want to consider some of Jeffrey Talpins’ third quarter top stock picks. For those of you who never heard of Jeffrey Talpins, we’ll provide some basic background. He is the founder and portfolio manager of one of the biggest hedge funds that […]

  • Motley Fool10 days ago

    How to Put the Right Priorities Into Your Finances

    Should you buy insurance? Sell a winner? Pay off low-interest loans early?

  • Reuters10 days ago

    Medtronic to pay $51 mln to resolve U.S. medical device probes

    Medtronic Plc said on Tuesday it would pay $50.9 million to resolve U.S. Justice Department probes into how companies it later acquired marketed medical devices, including one meant to treat a vascular defect in the brain. As part of the accord, ev3 Inc, which Medtronic now owns, will pay $17.9 million and plead guilty to a charge related to its marketing of a neurovascular medical device for unproven and potentially dangerous uses, federal prosecutors in Boston said. The misdemeanor charge relates to the Onyx Liquid Embolic System, which the U.S. Food and Drug Administration in 2005 approved for the limited use of blocking blood flow to arteriovenous malformations in the brain.

  • Medtronic Announces Worldwide Voluntary Field Corrective Action; Company Issues Software Update for Puritan Bennett(TM) 980 (PB980) Ventilator Series
    GlobeNewswire10 days ago

    Medtronic Announces Worldwide Voluntary Field Corrective Action; Company Issues Software Update for Puritan Bennett(TM) 980 (PB980) Ventilator Series

    December 4, 2018 - Medtronic (MDT) is notifying customers worldwide of a voluntary field corrective action for its Puritan Bennett(TM) 980 (PB980) ventilator series. Medtronic initiated this field action on September 19, 2018. A Puritan Bennett 980 ventilator is a mechanical ventilator used to support a patient`s breathing. The voluntary field corrective action is a software update to address customer feedback.

  • Big Corporations Are Investing in Surgical Robots. Should You?
    Motley Fool10 days ago

    Big Corporations Are Investing in Surgical Robots. Should You?

    Surgical robots are increasingly being placed in hospital operating rooms. AlphaCentric Global Innovation's portfolio manager names a few investment opportunities in this fast-growing space.

  • How IBM Is Investing in AI Solutions
    Market Realist11 days ago

    How IBM Is Investing in AI Solutions

    AI is the buzzword these days, and the market has huge growth potential. PR Newswire, citing QY Research, reported that the global AI market could grow 52.6% (compounded annually) from $2.65 billion in 2017 to $78 billion by 2025. IBM (IBM) has been the largest player in the AI market.

  • Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
    Zacks11 days ago

    Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know

    Medtronic (MDT) closed the most recent trading day at $98.75, moving +1.25% from the previous trading session.

  • Don’t Sell Medtronic plc (NYSE:MDT) Before You Read This
    Simply Wall St.12 days ago

    Don’t Sell Medtronic plc (NYSE:MDT) Before You Read This

    This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We’ll look at Medtronic plc’s (NYSE:MDT) P/E ratio and reflect on Read More...